Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry on Continuous Marketing Applications: Pilot-Scientific Feedback and Interactions During Development of Fast Track Products Under the Prescription Drug User Fee Act

Özet

The Food and Drug Administration (FDA) is announcing that a collection of information entitled " Guidance for Industry on Continuous Marketing Applications: Pilot--Scientific Feedback and Interactions During Development of Fast Track Products Under the Prescription Drug User Fee Act" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.